|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
|
DE3778626D1
(de)
|
1986-09-27 |
1992-06-04 |
Toyo Jozo Kk |
Nukleosid-phospholipid-konjugat.
|
|
US7517858B1
(en)
|
1995-06-07 |
2009-04-14 |
The Regents Of The University Of California |
Prodrugs of pharmaceuticals with improved bioavailability
|
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
DE60038038T2
(de)
|
1999-12-03 |
2009-02-12 |
The Regents of The University of California at San Diego, La Jolla |
Phosphonatverbindungen
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
CN100490818C
(zh)
|
2000-05-26 |
2009-05-27 |
诺瓦蒂斯有限公司 |
β-L-2′-脱氧核苷在制备用于治疗丁型肝炎病毒感染的药物中的用途
|
|
AUPR213700A0
(en)
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
JP5030587B2
(ja)
|
2003-06-26 |
2012-09-19 |
バイオトロン・リミテッド |
抗ウイルスアシルグアニジン化合物および方法
|
|
MY145634A
(en)
*
|
2003-12-29 |
2012-03-15 |
Bristol Myers Squibb Co |
Pyrrolotriazine compounds as kinase inhibitors
|
|
EP1831235B1
(en)
|
2004-12-16 |
2013-02-20 |
The Regents of The University of California |
Lung-targeted drugs
|
|
WO2006130217A2
(en)
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
|
DK2826770T3
(en)
|
2005-06-24 |
2019-01-07 |
Biotron Ltd |
Acylguanidine compounds with antiviral activity
|
|
WO2009018609A1
(en)
|
2007-08-03 |
2009-02-12 |
Biotrom Limited |
Hepatitis c antiviral compositions and methods
|
|
CN102015714B
(zh)
|
2008-04-23 |
2014-09-24 |
吉里德科学公司 |
用于抗病毒治疗的1’-取代的carba-核苷类似物
|
|
WO2010002877A2
(en)
|
2008-07-03 |
2010-01-07 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
|
AU2009298802A1
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
CA2740726A1
(en)
|
2008-11-06 |
2010-05-14 |
Vascular Biogenics Ltd. |
Oxidized lipid compounds and uses thereof
|
|
BR112012006180A2
(pt)
|
2009-09-21 |
2015-09-08 |
Gilead Sciences Inc |
processos e intermediários para a preparação de análogos de 1'-substituido carba-nucleosídeo
|
|
SMT201700091T1
(it)
|
2009-09-21 |
2017-03-08 |
Gilead Sciences Inc |
ANALOGHI CARBA-NUCLEOSIDlCI2'-FLUORO SOSTITUITI PER TRATTAMENTO ANTIVIRALE
|
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
US8933229B2
(en)
|
2009-11-11 |
2015-01-13 |
Sumitomo Dainippon Pharma Co., Ltd. |
8-azabicyclo[3.2.1]octane-8-carboxamide derivative
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
|
PT2596004E
(pt)
|
2010-07-19 |
2014-11-28 |
Gilead Sciences Inc |
Métodos para a preparação de pró-fármacos de fosforamidato diastereomericamente puros
|
|
SG186830A1
(en)
|
2010-07-22 |
2013-02-28 |
Gilead Sciences Inc |
Methods and compounds for treating paramyxoviridae virus infections
|
|
SMT201800662T1
(it)
|
2011-12-22 |
2019-01-11 |
Alios Biopharma Inc |
Nucleotidi, nucleosidi sostituiti e loro analoghi
|
|
EP2892893B2
(en)
|
2012-09-10 |
2019-10-16 |
F.Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
EP3912984A1
(en)
|
2012-12-21 |
2021-11-24 |
Janssen BioPharma, Inc. |
4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv
|
|
TWI642677B
(zh)
|
2013-03-15 |
2018-12-01 |
美國加利福尼亞大學董事會 |
非環狀核苷膦酸二酯
|
|
EP3013340B9
(en)
|
2013-06-26 |
2023-10-04 |
Janssen Pharmaceuticals, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
MX377523B
(es)
|
2013-09-11 |
2025-03-10 |
Inst Nat Sante Rech Med |
Metodos y composiciones farmaceuticas para el tratamiento de la infeccion por el virus de la hepatitis b.
|
|
SG10201804835VA
(en)
|
2013-10-11 |
2018-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
|
WO2015113990A1
(en)
|
2014-01-30 |
2015-08-06 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
|
HUE041734T2
(hu)
|
2014-03-07 |
2019-05-28 |
Hoffmann La Roche |
Új, 6-tagú gyûrûvel kondenzált heteroarildihidropirimidinek hepatitisz B vírusfertõzés kezelésére és megelõzésére
|
|
CA2948080A1
(en)
|
2014-05-13 |
2015-11-19 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
|
CN106573011A
(zh)
|
2014-06-24 |
2017-04-19 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸和其类似物
|
|
TN2016000566A1
(en)
|
2014-06-24 |
2018-04-04 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
|
KR101891933B1
(ko)
|
2014-08-14 |
2018-08-24 |
에프. 호프만-라 로슈 아게 |
B형 간염 바이러스 감염의 치료 또는 예방을 위한 신규한 피리다존 및 트라이아진온
|
|
TWI687432B
(zh)
|
2014-10-29 |
2020-03-11 |
美商基利科學股份有限公司 |
絲狀病毒科病毒感染之治療
|
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
|
AR103222A1
(es)
|
2014-12-23 |
2017-04-26 |
Hoffmann La Roche |
Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina
|
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
|
WO2016107832A1
(en)
|
2014-12-30 |
2016-07-07 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection
|
|
CN107109497A
(zh)
|
2014-12-31 |
2017-08-29 |
豪夫迈·罗氏有限公司 |
通过实时PCR从细胞裂解物定量HBV cccDNA的高通量新方法
|
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
|
EP3250685A1
(en)
|
2015-01-27 |
2017-12-06 |
F. Hoffmann-La Roche AG |
Recombinant hbv cccdna, the method to generate thereof and the use thereof
|
|
HK1244281B
(zh)
|
2015-02-11 |
2020-02-07 |
F. Hoffmann-La Roche Ag |
治疗和预防乙型肝炎病毒感染的2-氧代-6，7-二氢苯并[a]喹嗪-3-甲酸衍生物
|
|
EA201890454A1
(ru)
|
2015-08-06 |
2018-07-31 |
Чимерикс, Инк. |
Пирролопиримидиновые нуклеозиды и их аналоги, которые можно использовать в качестве противовирусных средств
|
|
BR122020020217B1
(pt)
|
2015-09-16 |
2021-08-17 |
Gilead Sciences, Inc |
Uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por arenaviridae
|
|
US10874683B2
(en)
|
2016-03-10 |
2020-12-29 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
|
US11963972B2
(en)
|
2016-03-23 |
2024-04-23 |
Emory University |
Antiviral agents and nucleoside analogs for treatment of Zika virus
|
|
KR102607599B1
(ko)
|
2017-02-08 |
2023-11-28 |
바이오트론 리미티드 |
인플루엔자의 치료 방법
|
|
EP4331677A3
(en)
|
2017-03-14 |
2024-05-29 |
Gilead Sciences, Inc. |
Methods of treating feline coronavirus infections
|
|
EP3661513A4
(en)
|
2017-07-31 |
2021-07-14 |
January Therapeutics, Inc. |
ORGANOPHOSPHATE DERIVATIVES
|
|
US11149049B2
(en)
|
2017-09-18 |
2021-10-19 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
EP3732180A4
(en)
|
2017-12-27 |
2022-05-11 |
Emory University |
COMBINED MODALITIES FOR NUCLEOSIDES AND/OR NADPH OXIDASE (NOX) INHIBITORS AS MYELOID-SPECIFIC ANTIVIRALS
|
|
CN110054616B
(zh)
*
|
2018-01-19 |
2021-11-23 |
南京圣和药业股份有限公司 |
三嗪类idh抑制剂的制备方法
|
|
CN112218533A
(zh)
|
2018-03-02 |
2021-01-12 |
詹纽瑞治疗公司 |
纳米颗粒组合物
|
|
CN114667298A
(zh)
|
2019-11-04 |
2022-06-24 |
艾利妥 |
Siglec-9 ecd融合分子及其使用方法
|
|
TWI791193B
(zh)
*
|
2020-02-18 |
2023-02-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
CN113292565B
(zh)
|
2020-02-24 |
2023-01-31 |
浙江森科建设有限公司 |
核苷类化合物及其制备方法和应用
|
|
CN111233929B
(zh)
|
2020-02-28 |
2023-02-28 |
成都阿奇生物医药科技有限公司 |
一种核苷类似物的氘代物及其制备方法和用途
|
|
CN111393243B
(zh)
|
2020-04-22 |
2022-12-13 |
深圳市宝安区新材料研究院 |
一种磷手性核苷类药物的合成方法及该方法得到的药物
|
|
JP2023535065A
(ja)
*
|
2020-07-24 |
2023-08-15 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
抗ウイルスプロドラッグ、医薬製剤、及び方法
|
|
CN116323630A
(zh)
|
2020-08-24 |
2023-06-23 |
吉利德科学公司 |
磷脂化合物及其用途
|
|
CN112010916B
(zh)
|
2020-09-09 |
2022-12-27 |
广东东阳光药业有限公司 |
核苷化合物的氨基磷酸酯衍生物及其用途
|
|
MX2023003362A
(es)
|
2020-09-23 |
2023-05-30 |
Scorpion Therapeutics Inc |
Derivados de pirrolo[3,2-c]piridin-4-ona utiles en el tratamiento del cancer.
|
|
US20240034723A1
(en)
|
2020-10-16 |
2024-02-01 |
Dana-Farber Cancer Institute, Inc. |
Piperidinyl small molecule degraders of helios and methods of use
|
|
TWI811812B
(zh)
|
2020-10-16 |
2023-08-11 |
美商基利科學股份有限公司 |
磷脂化合物及其用途
|
|
US12083099B2
(en)
|
2020-10-28 |
2024-09-10 |
Accencio LLC |
Methods of treating symptoms of coronavirus infection with viral protease inhibitors
|
|
CN112645982B
(zh)
|
2020-12-22 |
2023-04-07 |
苏州正济药业有限公司 |
一种瑞德西韦关键中间体的制备和纯化方法
|
|
AU2022222458A1
(en)
|
2021-02-19 |
2023-08-24 |
Kalvista Pharmaceuticals Limited |
Factor xiia inhibitors
|
|
US11795159B2
(en)
|
2021-05-26 |
2023-10-24 |
Purdue Research Foundation |
Compounds for the treatment of SARS
|
|
US11834408B2
(en)
|
2021-05-28 |
2023-12-05 |
Purdue Research Foundation |
Compounds for the treatment of SARS
|
|
EP4355755A4
(en)
|
2021-06-14 |
2025-05-07 |
Venatorx Pharmaceuticals, Inc. |
ORALLY BIOAVAILABLE NUCLEOSIDE ANALOGUES
|
|
CN115475171B
(zh)
|
2021-06-16 |
2025-03-07 |
中国医学科学院医药生物技术研究所 |
一种具有抗冠状病毒活性的化合物及其应用
|
|
JPWO2022270478A1
(pl)
|
2021-06-21 |
2022-12-29 |
|
|
|
CN115504940A
(zh)
|
2021-06-23 |
2022-12-23 |
中国科学院上海药物研究所 |
一种酰胺类化合物、其制备方法和制药用途
|
|
WO2022268111A1
(zh)
|
2021-06-25 |
2022-12-29 |
前沿生物药业(南京)股份有限公司 |
抗病毒药物组合物及其制备方法和应用
|
|
KR102766444B1
(ko)
|
2021-06-28 |
2025-02-11 |
재단법인 대구경북첨단의료산업진흥재단 |
트리아지노인돌 유도체를 유효성분으로 하는 항바이러스제
|
|
US20240293384A1
(en)
|
2021-06-29 |
2024-09-05 |
The Regents Of The University Of California |
Methods and compositions for treatment of covid-19
|
|
WO2023272571A1
(zh)
|
2021-06-30 |
2023-01-05 |
中国人民解放军军事科学院军事医学研究院 |
2,3-环氧丁二酰衍生物的医药用途
|
|
EP4366717A1
(en)
|
2021-07-08 |
2024-05-15 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Broad-spectrum antiviral drugs
|
|
IL309732A
(en)
|
2021-07-09 |
2024-02-01 |
Aligos Therapeutics Inc |
Antiviral compounds
|
|
WO2023283831A1
(zh)
|
2021-07-14 |
2023-01-19 |
上海药明康德新药开发有限公司 |
病毒主蛋白酶抑制剂及其制备方法和用途
|
|
EP4119145A1
(en)
|
2021-07-15 |
2023-01-18 |
Dompe' Farmaceutici S.P.A. |
Compounds for the treatment of covid-19
|
|
WO2023286844A1
(ja)
|
2021-07-15 |
2023-01-19 |
国立研究開発法人国立国際医療研究センター |
抗ウイルス活性等の生理活性を有する化合物
|
|
WO2023004291A1
(en)
|
2021-07-19 |
2023-01-26 |
Baylor College Of Medicine |
Coronavirus main protease inhibitors and methods using same
|
|
TW202321210A
(zh)
|
2021-07-22 |
2023-06-01 |
瑞士商諾華公司 |
用於治療冠狀病毒相關疾病之化合物及組成物
|
|
WO2023003610A1
(en)
|
2021-07-23 |
2023-01-26 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
|
KR102806503B1
(ko)
|
2021-07-29 |
2025-05-16 |
가톨릭대학교 산학협력단 |
렘데시비르와 면역조절제 병용투여법을 통한 자가면역류마티스 질환 치료용 조성물
|
|
WO2023009187A1
(en)
|
2021-07-29 |
2023-02-02 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
|
US20240325386A1
(en)
|
2021-07-30 |
2024-10-03 |
Fujifilm Toyama Chemical Co., Ltd. |
Therapeutic agent for covid-19
|
|
JP2024529062A
(ja)
|
2021-08-02 |
2024-08-01 |
北京華益健康薬物研究中心 |
コロナウイルス感染症の治療又は予防のための３ｃｌプロテア－ゼ小分子阻害剤及びその用途
|
|
TW202321196A
(zh)
|
2021-08-03 |
2023-06-01 |
美商共結晶製藥公司 |
冠狀病毒抑制劑
|
|
EP4130001A1
(en)
|
2021-08-03 |
2023-02-08 |
Studiengesellschaft Kohle mbH |
Process for the direct catalytic glycosylation of arenes
|
|
BR112024002195A2
(pt)
|
2021-08-06 |
2024-04-30 |
Intervet Int Bv |
USOS DE UM NUCLEOSÍDEO ANTIVIRAL ß-d-N(4)-HIDROXICITIDINA PARA PREVENIR OU TRATAR UMA DOENÇA VIRAL OU PARA INDUZIR UMA RESPOSTA ANTIVIRAL EM UM ANIMAL
|
|
CN115703796A
(zh)
|
2021-08-09 |
2023-02-17 |
苏州恩泰新材料科技有限公司 |
一种瑞德西韦重要中间体制备方法
|
|
JP2023026155A
(ja)
|
2021-08-13 |
2023-02-24 |
国立研究開発法人理化学研究所 |
感染症治療薬
|
|
WO2023039330A2
(en)
|
2021-08-17 |
2023-03-16 |
Southwest Research Institute |
Antiviral drugs targeting the n-terminal domain (ntd) of the coronavirus spike receptor binding domain (rbd)
|
|
EP4387733A4
(en)
|
2021-08-17 |
2025-06-04 |
Southwest Research Institute |
CORONAVIRUS INHIBITORS
|
|
WO2023021092A1
(en)
|
2021-08-17 |
2023-02-23 |
Farahani Ensieh |
Compounds for treatment of viral infections by neurotropic virus
|
|
KR20240049311A
(ko)
*
|
2021-08-18 |
2024-04-16 |
길리애드 사이언시즈, 인코포레이티드 |
인지질 화합물 및 이의 제조 및 사용 방법
|
|
EP4387980A1
(en)
|
2021-08-18 |
2024-06-26 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
EP4387629A1
(en)
|
2021-08-18 |
2024-06-26 |
Katholieke Universiteit Leuven KU Leuven Research & Development |
6-substituted- and 6,7-disubstituted-7-deazapurine ribonucleoside analogues
|
|
US20240391876A1
(en)
|
2021-08-19 |
2024-11-28 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Quinacrine and derivatives thereof for treatment of viral infections
|
|
CN113648293B
(zh)
|
2021-08-19 |
2022-07-05 |
山东达因海洋生物制药股份有限公司 |
对苯醌和/或对苯醌衍生物在制备抗新型冠状病毒药物中的应用
|
|
JPWO2023022231A1
(pl)
|
2021-08-20 |
2023-02-23 |
|
|
|
CA3229752A1
(en)
|
2021-08-20 |
2023-02-23 |
Shionogi & Co., Ltd. |
Nucleoside derivatives and prodrugs thereof having viral growth inhibitory action
|
|
CN115716833A
(zh)
|
2021-08-26 |
2023-02-28 |
苏州旺山旺水生物医药有限公司 |
一种抗病毒核苷类似物的制备方法
|
|
CN115960148B
(zh)
|
2021-08-27 |
2023-12-12 |
南京知和医药科技有限公司 |
一种新型的胞苷衍生物及其药物组合物和用途
|
|
US12234202B2
(en)
|
2021-08-27 |
2025-02-25 |
Ut-Battelle, Llc |
Covalent inhibitors of coronavirus papain-like protease
|
|
EP4396175A1
(en)
|
2021-08-31 |
2024-07-10 |
Pardes Biosciences, Inc. |
Crystalline inhibitors of cysteine proteases and methods of use thereof
|
|
CN115721661A
(zh)
|
2021-09-01 |
2023-03-03 |
常晓宇 |
嘌呤核苷类药物预防或治疗冠状病毒感染性疾病的用途
|
|
CN115745960B
(zh)
|
2021-09-02 |
2024-08-30 |
中国科学院上海药物研究所 |
一类含喹啉酮酰胺的化合物及其制备方法、药物组合物和用途
|
|
CN115737665A
(zh)
|
2021-09-02 |
2023-03-07 |
广州谷森制药有限公司 |
胞苷衍生物和与其相关的抗病毒用途
|
|
JP2024178473A
(ja)
|
2021-09-03 |
2024-12-25 |
塩野義製薬株式会社 |
ウイルス増殖阻害活性を有する二環性含窒素複素環誘導体およびそれらを含有する医薬組成物
|
|
CN118076593A
(zh)
|
2021-09-07 |
2024-05-24 |
上海齐鲁制药研究中心有限公司 |
3CLpro蛋白酶抑制剂
|
|
EP4357342A4
(en)
|
2021-09-09 |
2024-10-30 |
Guangdong Raynovent Biotech Co., Ltd. |
Ketoamide derivative and application thereof
|
|
EP4148042A1
(en)
|
2021-09-10 |
2023-03-15 |
Centre National de la Recherche Scientifique |
Phenoxy-acetyl-thioureido-benzenesulfonamide derivatives, and their uses
|
|
WO2023043830A1
(en)
|
2021-09-15 |
2023-03-23 |
Clear Creek Bio, Inc. |
Combination therapies to treat viral infections
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
WO2023042879A1
(ja)
|
2021-09-17 |
2023-03-23 |
塩野義製薬株式会社 |
ウイルス増殖阻害活性を有する二環性複素環誘導体およびそれらを含有する医薬組成物
|
|
CN115819391A
(zh)
|
2021-09-17 |
2023-03-21 |
中国科学院上海药物研究所 |
一类黄芩素衍生物、其制备方法和用途
|
|
WO2023044462A1
(en)
|
2021-09-17 |
2023-03-23 |
Pardes Biosciences, Inc. |
Cysteine protease inhibitor formulations and method of use thereof
|
|
CN115554303B
(zh)
|
2021-09-18 |
2024-07-09 |
上海科技大学 |
一种三环类化合物、其制备方法及其应用
|
|
WO2023044171A1
(en)
|
2021-09-20 |
2023-03-23 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
WO2023048151A1
(ja)
|
2021-09-22 |
2023-03-30 |
塩野義製薬株式会社 |
ウイルス増殖阻害活性を有する環状ペプチド
|
|
WO2023049643A1
(en)
|
2021-09-23 |
2023-03-30 |
City Of Hope |
Inhibitors of sars-cov-2
|
|
EP4405357A1
(en)
|
2021-09-23 |
2024-07-31 |
Katholieke Universiteit Leuven KU Leuven Research & Development |
Ribonucleoside analogues against -sars-cov-2
|
|
US12186309B2
(en)
|
2021-09-27 |
2025-01-07 |
The Governors Of The University Of Alberta |
RNA virus inhibitor compounds and uses thereof
|
|
TW202330513A
(zh)
|
2021-09-28 |
2023-08-01 |
加拿大商愛彼特生物製藥公司 |
)抑制劑及其使用方法
|
|
WO2023054292A1
(ja)
|
2021-09-28 |
2023-04-06 |
塩野義製薬株式会社 |
トリアジン誘導体を含有する医薬組成物
|
|
CN115894587A
(zh)
|
2021-09-30 |
2023-04-04 |
知和(山东)大药厂有限公司 |
一种核苷衍生物的制备及其在抗病毒药物领域中的用途
|
|
EP4159721A1
(en)
|
2021-09-30 |
2023-04-05 |
Qubit Pharmaceuticals |
Condensed 3,3-difluoro-piperidine derivatives as inhibitors of coronaviruses 3-chymotrypsin-like protease
|
|
GB202114032D0
(en)
|
2021-09-30 |
2021-11-17 |
Univ Strathclyde |
Antivirals
|
|
AU2022357033A1
(en)
|
2021-09-30 |
2024-03-21 |
Hainan Simcere Pharmaceutical Co., Ltd. |
Cyano compound, and preparation method therefor and use thereof
|
|
WO2023054759A1
(ko)
|
2021-09-30 |
2023-04-06 |
한국화학연구원 |
2-아미노퀴나졸린 유도체 및 이를 포함하는 항바이러스용 조성물
|
|
KR20230049329A
(ko)
|
2021-10-06 |
2023-04-13 |
(주)스파크바이오파마 |
피리미도디아제핀계 화합물 및 코로나바이러스 감염의 치료 또는 예방을 위한 이의 용도
|
|
WO2023059792A1
(en)
|
2021-10-06 |
2023-04-13 |
C4 Thrapeutics, Inc. |
Coronavirus non-structural protein 3 degrading compounds
|
|
CN115947758A
(zh)
|
2021-10-07 |
2023-04-11 |
南京知和医药科技有限公司 |
一种核苷酸衍生物及其药物组合物和用途
|
|
WO2023063884A2
(en)
|
2021-10-12 |
2023-04-20 |
Nanyang Technological University |
Generation of chiral sulfinate esters
|
|
CA3235441A1
(en)
|
2021-10-13 |
2023-04-20 |
Clear Creek Bio, Inc. |
Compounds and methods for treating coronaviruses
|
|
CN115710297A
(zh)
|
2021-10-20 |
2023-02-24 |
知和(山东)大药厂有限公司 |
一种新型核苷酸衍生物类及其药物组合物和用途
|
|
AU2022382054B2
(en)
|
2021-11-04 |
2025-10-23 |
Shenzhen Antiv Pharma Co., Ltd. |
Crystal form of isobutyrate nucleoside compound, and preparation method
|
|
CN115806570B
(zh)
|
2021-11-15 |
2023-09-12 |
南京知和医药科技有限公司 |
一种拟肽衍生物及其药物组合物和用途
|
|
EP4289432A4
(en)
|
2021-11-24 |
2025-01-15 |
Shionogi & Co., Ltd |
PREPARATION FOR ORAL ADMINISTRATION CONTAINING TRIAZINE DERIVATIVES
|
|
US11541071B1
(en)
|
2021-12-16 |
2023-01-03 |
Ascletis BioScience Co., Ltd |
Nucleoside derivatives and methods of use thereof
|
|
CN115518058A
(zh)
|
2021-12-29 |
2022-12-27 |
河北医科大学 |
N-环烷基取代的芳甲胺类化合物在制备抗病毒药物中的用途及结构和制备方法
|
|
US11760722B2
(en)
|
2022-01-18 |
2023-09-19 |
Ascletis Bioscience Co., Ltd. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
WO2023054732A2
(ja)
|
2022-01-19 |
2023-04-06 |
塩野義製薬株式会社 |
新型コロナウイルス感染症治療用医薬
|
|
CN116925040B
(zh)
|
2022-03-31 |
2025-07-29 |
陕西盘龙药业集团股份有限公司 |
一种靶向冠状病毒3CL蛋白酶的PROTACs及其制备方法与应用
|
|
CN115504964A
(zh)
|
2022-04-12 |
2022-12-23 |
海创药业股份有限公司 |
氘代杂环酮类化合物及其用途
|
|
CN115650959B
(zh)
|
2022-05-20 |
2023-10-20 |
南京济群医药科技股份有限公司 |
化合物的制备方法或纯化方法
|
|
CN115636817B
(zh)
|
2022-06-20 |
2023-11-24 |
山东大学 |
含三唑环的靛红类衍生物及其制备方法与应用
|
|
CN116496266A
(zh)
|
2022-07-08 |
2023-07-28 |
歌礼生物科技（杭州）有限公司 |
三嗪衍生物
|
|
CN115572298B
(zh)
|
2022-07-22 |
2024-11-08 |
苏州旺山旺水生物医药股份有限公司 |
一种核苷类似物及其盐的晶型、制备方法和应用
|
|
CN115466225B
(zh)
|
2022-08-16 |
2025-03-07 |
中国科学院上海药物研究所 |
一种酰胺类化合物及其制备方法、药物组合物和用途
|
|
CN115521208B
(zh)
|
2022-09-21 |
2023-09-01 |
天津科技大学 |
新型冠状病毒3cl蛋白酶抑制剂和应用
|
|
CN115521316B
(zh)
|
2022-09-23 |
2024-07-26 |
深圳安泰维生物医药有限公司 |
一种核苷类化合物或其中间体的制备方法和核苷类化合物的中间体
|
|
CN115521337A
(zh)
|
2022-09-26 |
2022-12-27 |
南京康立瑞生物科技有限公司 |
一种瑞德西韦中间体的合成方法
|
|
CN115894498A
(zh)
|
2022-10-01 |
2023-04-04 |
海化生命(厦门)科技有限公司 |
一种潜在抗病毒药物中间体bl及其合成方法
|
|
US11655255B2
(en)
|
2022-10-17 |
2023-05-23 |
Sph No.1 Biochemical & Pharmaceutical Co., Ltd. |
Method for catalytic asymmetric synthesis of phosphorus-stereogenic (P-stereogenic) nucleoside derivative and catalyst used therein
|
|
CN115894504A
(zh)
|
2022-10-21 |
2023-04-04 |
深圳信立泰药业股份有限公司 |
一种冠状病毒3cl蛋白酶抑制剂及其用途
|
|
CN115651022A
(zh)
|
2022-10-27 |
2023-01-31 |
南京康立瑞生物科技有限公司 |
一种高纯度瑞德西韦中间体的合成方法
|
|
CN115887471B
(zh)
|
2022-11-01 |
2024-02-13 |
南开大学 |
瑞德西韦在制备治疗皮肤纤维化疾病药物中的应用
|
|
CN115894443B
(zh)
|
2022-11-17 |
2024-03-29 |
上海市重大传染病和生物安全研究院 |
一种化合物艾奎斯韦及其应用
|
|
CN116514783A
(zh)
|
2022-11-21 |
2023-08-01 |
歌礼生物科技（杭州）有限公司 |
三嗪衍生物
|
|
CN115819423B
(zh)
|
2022-11-29 |
2024-11-22 |
武汉大学 |
一种瑞德西韦或其中间体的protac化合物及其制备方法与抗ev71的应用
|
|
CN115850338A
(zh)
|
2022-12-12 |
2023-03-28 |
西安交通大学 |
一种含有双吖丙啶核苷类化合物及制备方法和应用
|
|
CN115947759A
(zh)
|
2022-12-13 |
2023-04-11 |
安徽大学 |
一种治疗新冠药物瑞德西韦的制备方法
|
|
CN115785080B
(zh)
|
2022-12-16 |
2024-10-11 |
陕西盘龙药业集团股份有限公司 |
一种尿嘧啶母核类化合物及其制备方法和应用
|